Mumps Virus Vaccine Live Market - Global Forecast 2026-2032

The live mumps virus vaccine market is entering a period of rapid evolution, with global immunization strategies, regulatory frameworks, and resilient supply chains shaping the environment for senior decision-makers. Organizations must promptly adapt, balancing agility and reliability amidst shifting demands.

Market Snapshot: Growth and Trends in the Live Mumps Virus Vaccine Market

The Mumps Virus Vaccine Live Market demonstrated robust expansion, rising from USD 794.24 million in 2025 to USD 857.01 million in 2026, achieving a compound annual growth rate (CAGR) of 7.36%. The market is anticipated to reach USD 1.30 billion by 2032. This momentum is propelled by broad immunization campaigns, improvements to supply dependability, and modernization throughout regulatory systems worldwide. The live mumps virus vaccine segment remains central as governments and stakeholders respond to evolving public health priorities and seek reliable vaccine access in diverse geographic regions.

Scope & Segmentation

Product Composition: Covers both combined measles-mumps-rubella (MMR) vaccines and monovalent forms, addressing routine immunization and outbreak-specific needs in different settings.
Strain & Design: Focuses on strains verified for long-term efficacy, immunogenicity, and adaptability, with a strong emphasis on scalable and consistently reproducible manufacturing methods.
Age Cohorts: Addresses foundational pediatric schedules, adolescent catch-up programs, adult boosters, and occupational risk group coverage.
Distribution Channels: Encompasses mass immunization initiatives, clinical environments such as hospitals and clinics, and pharmacy-led approaches, enabling both high-volume throughput and broad public access.
End-Use Settings: Serves national vaccination efforts and institutions, including universities, military installations, and other settings with dense populations or heightened exposure risk.
Geographic Regions: Includes established programs in the Americas, EMEA’s structured procurement and compliance, the expanding Asia-Pacific supplier network, and the diverse access landscape of the Middle East and Africa.
Technology & Manufacturing: Integrates live attenuated viral propagation, advanced fill-finish processes, quality-by-design controls, and packaging innovations to maintain product efficacy and integrity through robust cold-chain systems.

Key Takeaways for Senior Decision-Makers

Agility in operations is necessary to respond to outbreaks, even in regions with high vaccination coverage, as rapid distribution and surge planning remain top priorities.
Increasing regulatory scrutiny around quality, consistency, and contamination control is accelerating the adoption of data-driven analytics and rigorous release testing in production environments.
Procurement strategies now emphasize uninterrupted supply, including performance-based agreements, multi-sourcing, and partnerships that mitigate supply chain risks.
Stakeholder involvement spans public confidence-building, catch-up vaccination campaigns, and coordinated outbreak responses in areas requiring strengthened vaccine acceptance.
Regional diversity in policy, regulatory systems, and market access calls for tailored evidence, targeted partnerships, and adaptable distribution models to ensure reliable long-term supply.
Competitive positioning now concentrates on quality system robustness, agile fill-finish capabilities, and trusted collaborations with public health sectors.

Tariff Impact on the Live Mumps Virus Vaccine Value Chain

Anticipated tariff shifts in the United States could increase upstream costs and operational complexity for live mumps virus vaccine manufacturers. These changes primarily affect input purchases such as cold-chain equipment, packaging materials, and bioprocessing components. Organizations are expected to safeguard against exposure by broadening supplier networks and renegotiating long-term contracts, yet regulatory transitions and approval requirements may complicate sourcing changes. Investments in multi-regional manufacturing and resilient logistics processes offer critical risk mitigation, minimizing susceptibility to supply disruptions and administrative delays.

Methodology & Data Sources

This report is built on extensive primary research, including expert interviews with vaccine manufacturers, supply chain professionals, frontline clinicians, and public health authorities. Secondary reviews covered regulatory documents, scientific publications, procurement practices, and confidential supplier communications. The triangulated methodology ensures actionable and balanced insights that align with current best practices in the live mumps virus vaccine market.

Why This Report Matters

Enables leaders to identify strategic exposure points and discover new opportunities, supporting timely adaptation to changing outbreak dynamics and procurement models.
Provides guidance for investment in manufacturing modernization, embracing advanced quality-by-design processes and contract mechanisms that ensure seamless compliance and operational continuity.
Supports coordinated alignment across operations, medical, and regulatory teams, bolstering effective immunization coverage, agile response, and sustained stakeholder trust.

Conclusion

Sustained success in the live mumps virus vaccine market requires integrated focus on supply reliability, manufacturing excellence, and regional policy acuity. Prioritizing stakeholder engagement and operational flexibility strengthens organizational capacity to deliver consistent immunization outcomes at scale.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Mumps Virus Vaccine Live Market, by Vaccine Type

8.1. Combination Vaccine
8.1.1. Mmr Vaccine
8.1.2. MmrV Vaccine
8.2. Monovalent Vaccine

9. Mumps Virus Vaccine Live Market, by Age Group

9.1. Adolescent
9.2. Adult
9.3. Pediatric

10. Mumps Virus Vaccine Live Market, by Technology

10.1. Dna Vaccine
10.2. Live Attenuated Vaccine
10.3. Recombinant Vaccine

11. Mumps Virus Vaccine Live Market, by Route Of Administration

11.1. Intramuscular
11.2. Subcutaneous

12. Mumps Virus Vaccine Live Market, by Dose Type

12.1. Multi Dose
12.2. Single Dose

13. Mumps Virus Vaccine Live Market, by Formulation

13.1. Liquid Solution
13.2. Lyophilized Powder

14. Mumps Virus Vaccine Live Market, by Distribution Channel

14.1. Clinic
14.1.1. Community Clinic
14.1.2. Specialty Clinic
14.2. Hospital Pharmacy
14.2.1. Private Hospital
14.2.2. Public Hospital
14.3. Online Pharmacy
14.3.1. Direct To Consumer Pharmacy
14.3.2. Third Party Marketplace
14.4. Retail Pharmacy
14.4.1. Chain Pharmacy
14.4.2. Independent Pharmacy

15. Mumps Virus Vaccine Live Market, by Region

15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific

16. Mumps Virus Vaccine Live Market, by Group

16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO

17. Mumps Virus Vaccine Live Market, by Country

17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea

18. United States Mumps Virus Vaccine Live Market
19. China Mumps Virus Vaccine Live Market

20. Competitive Landscape

20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. AstraZeneca
20.6. Bavarian Nordic
20.7. Bharat Biotech International Limited
20.8. Biological E. Limited
20.9. CSL Limited
20.10. GSK plc
20.11. Hualan Biological Engineering Inc.
20.12. Johnson & Johnson
20.13. Merck & Co., Inc.
20.14. Pfizer Inc.
20.15. Sanofi
20.16. Serum Institute of India Pvt. Ltd.
20.17. Sinovac Biotech Ltd.
20.18. Takeda Pharmaceutical Company Limited
20.19. Zydus Lifesciences Limited

List of Figures

FIGURE 1. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MMR VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MMR VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MMR VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MMRV VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MMRV VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MMRV VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MONOVALENT VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ADOLESCENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ADOLESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DNA VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DNA VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DNA VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RECOMBINANT VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RECOMBINANT VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LIQUID SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LIQUID SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LIQUID SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMMUNITY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMMUNITY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMMUNITY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DIRECT TO CONSUMER PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DIRECT TO CONSUMER PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DIRECT TO CONSUMER PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 151. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 155. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 159. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 161. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 162. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 163. EUROPE MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 177. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 179. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 180. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 181. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 182. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 184. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 185. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 186. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 187. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 188. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 189. AFRICA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 206. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 207. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 208. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 210. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 211. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 212. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 214. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 215. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 216. ASEAN MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 217. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 219. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 220. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 221. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 222. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 223. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 224. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 225. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 226. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 227. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 228. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 229. GCC MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 243. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 245. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 246. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 247. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 248. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 249. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 250. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 251. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 253. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 254. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 255. BRICS MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 256. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 257. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 258. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 259. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 260. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 261. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 262. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 263. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 264. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 265. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 266. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 267. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 268. G7 MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 269. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 270. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 271. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 272. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 273. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 274. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 275. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 276. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 277. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 278. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 279. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 280. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 281. NATO MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 282. GLOBAL MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 294. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 296. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 297. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 298. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY COMBINATION VACCINE, 2018-2032 (USD MILLION)
TABLE 299. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 300. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 301. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 302. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DOSE TYPE, 2018-2032 (USD MILLION)
TABLE 303. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 304. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 305. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
TABLE 306. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 307. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 308. CHINA MUMPS VIRUS VACCINE LIVE MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Mumps Virus Vaccine Live market report include:

AstraZeneca
Bavarian Nordic
Bharat Biotech International Limited
Biological E. Limited
CSL Limited
GSK plc
Hualan Biological Engineering Inc.
Johnson & Johnson
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Serum Institute of India Pvt. Ltd.
Sinovac Biotech Ltd.
Takeda Pharmaceutical Company Limited
Zydus Lifesciences Limited

Table Information

Report Attribute	Details
No. of Pages	186
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 857.01 Million
Forecasted Market Value ( USD ) by 2032	$ 1300 Million
Compound Annual Growth Rate	7.3%
Regions Covered	Global
No. of Companies Mentioned	16

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3419EUR$3,939USD£2,964GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3688EUR$4,249USD£3,198GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4999EUR$5,759USD£4,334GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6049EUR$6,969USD£5,245GBP

Market Snapshot: Growth and Trends in the Live Mumps Virus Vaccine Market

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact on the Live Mumps Virus Vaccine Value Chain

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Respiratory Virus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

Mumps Vaccine (MumpsVax) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Vaccine Market Report by Technology, Patient Type, Indication, Route of Administration, Product Type, Treatment Type, End User, Distribution Channel, and Region 2025-2033

Respiratory Virus Vaccines Market - Global Strategic Business Report

Chickenpox Vaccine Market Report 2025